SHERRIE RENAUD-CHARRON: Open Payments
NPI 1891719746 · BROWNSTOWN TWP, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$391 in 20 payments from 10 companies in 2025. Trend: 2023 $382 · 2024 $481 · 2025 $391
Food & beverage: $391
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $78 |
| Esperion Therapeutics, Inc. | 3 | $60 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $56 |
| Novartis Pharmaceuticals Corporation | 3 | $47 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| BridgeBio Pharma, Inc. | 1 | $29 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $25 |
| SCPHARMACEUTICALS INC. | 1 | $23 |
| Amgen Inc. | 1 | $20 |
| PFIZER INC. | 1 | $18 |
Products named: CAMZYOS, NEXLETOL, JARDIANCE, LEQVIO, FARXIGA, Attruby, LifeVest, FUROSCIX.
Industry payments across MI — which companies pay providers there.
